Inflammation Clinical Trial
Official title:
Systemic and Peritoneal Inflammatory Response In Robotic-assisted And Laparoscopic Surgery for Colon Cancer (SIRIRALS-trial): a Randomized Controlled Trial
The current hypothesis is that robotic-assisted surgery results in a reduced systemic and peritoneal inflammatory response (SIRS) compared to laparoscopic surgery in the treatment of colon cancer. The purpose is to evaluate differences in the peritoneal and systemic inflammatory response in robot-assisted and laparoscopic surgery of patients undergoing resection for colon cancer in a randomized, blinded controlled trial.
Status | Not yet recruiting |
Enrollment | 50 |
Est. completion date | September 1, 2022 |
Est. primary completion date | September 1, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion criteria - Elective robotic-assisted or laparoscopic surgery for right-sided, left-sided and sigmoid colon cancer - Aged = 18 - ASA-score = 3 - Tumor-stage (Tx-T4a) - Endoscopic suspected colon cancer - Histological verified adenocarcinoma, signet ring cell carcinoma, undifferentiated cancer, medullary carcinoma, or another malignant tumor type originating from colon - Patients must give informed written consent - Patients must be able to understand Danish language Exclusion criteria - Carcinoma of the transverse colon or synchronous colorectal cancer - Previous history of colon cancer - Previous open major abdominal surgery with exception of open appendectomy and cholecystectomy. - Metastatic disease - Pregnancy - History of psychiatric or addictive disorder that would prevent the patient from participating in the trial - Emergency colon surgery - Co-existing inflammatory bowel disease - Co-existing immunological disease that requiring ingestion of systemic immunomodulatory drugs (DMARD - disease modifying anti-rheumatic drugs), corticosteroids and biologic disease-modifying anti-rheumatic drugs. - Daily consumption of NSAID drugs |
Country | Name | City | State |
---|---|---|---|
Denmark | Hospital of Southern Denmark | Aabenraa |
Lead Sponsor | Collaborator |
---|---|
University of Southern Denmark | Region of Southern Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Levels of peritoneal inflammatory response in peritoneal fluid | Levels of cytokines are expressed by: Eotaxin, Eotaxin-3, GM-CSF, IFN-?, IL-1a, IL-1ß, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-8 (HA), IL-10, IL-12/IL-23p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IP-10, MCP-1, MCP-4, MDC, MIP-1a, MIP-1ß, TARC, TNF-a, TNF-ß, VEGF-A as well as IL-1RA and CRP. All cytokines are measured in pg/mL, CRP measured in mg/L | Postoperative (day 1-3) | |
Other | Patient reported health related quality of recovery (QoR-15) | Recovery is measured according to quality of recovery 15 score (QoR-15). The score ranges from 0-150. A high score indicates a good recovery. | Baseline and postoperative (day 1-3 and 14) | |
Other | Mortality | Number of mortality obtained from medical charts | 30 days | |
Other | Heart rate variability | The heart rate will continuously recorded by ECG intra- and postoperatively | Postoperative (day 1-3) | |
Other | Whole blood gene expression profiling | Gene mRNA transcript analysis | Baseline and postoperative (day 1-3) | |
Other | Time to local cancer recurrence or metastatic spread | The two surgical methods will be compared in order to obtain any differences in the local or metastatic cancer recurrence | 3 years postoperatively | |
Primary | Changes in levels of systemic inflammatory response expressed by CRP and IL-6 in serum between the two groups | CRP (mg/L), IL-6 (pg/mL) | Baseline and postoperative (day 1-3) | |
Secondary | Changes in levels of systemic inflammation in serum between the two groups | The cytokine levels are expressed by: Eotaxin, Eotaxin-3, GM-CSF, IFN-?, IL-1a, IL-1ß, IL-2, IL-4, IL-5, IL-7, IL-8, IL-8 (HA), IL-10, IL-12/IL-23p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IP-10, MCP-1, MCP-4, MDC, MIP-1a, MIP-1ß, TARC, TNF-a, TNF-ß, VEGF-A and IL-1RA. All cytokines are measured in pg/mL | Baseline and postoperative (day 1-3) | |
Secondary | Differences in number of patients with postoperative surgical and medical complications (30 days) according to Clavien-Dindo classification and Comprehensive Complication Index (CCI) | Number of complications obtained from medical records | 30 days | |
Secondary | Differences in intraoperative blood loss | Measured in mL | 1 day | |
Secondary | Conversion rate to open surgery | Number of conversions to open surgery | 1 day | |
Secondary | Length of surgery (total anesthesia time) | Measured in minutes | 1 day | |
Secondary | Length of surgery (total surgical time) | Measured in minutes | 1 day | |
Secondary | Lymph node yield | Pathological examination of lymph nodes | 14 days | |
Secondary | Length of hospital stay | Measured in days | 14 days | |
Secondary | Postoperative pain | Measured by VAS-scale | Baseline and postoperative (day 1-3 and 14) | |
Secondary | Time to first flatus | Measured in hours | Postoperative (day 1-3) | |
Secondary | Time to first bowel movement | Measured in hours | Postoperative (day 1-3) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03995979 -
Inflammation and Protein Restriction
|
N/A | |
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT03577223 -
Egg Effects on the Immunomodulatory Properties of HDL
|
N/A | |
Completed |
NCT04383561 -
Relationship Between LRG and Periodontal Disease
|
N/A | |
Active, not recruiting |
NCT03622632 -
Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
|
||
Completed |
NCT06216015 -
Exercise Training and Kidney Transplantation
|
N/A | |
Completed |
NCT04856748 -
Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT05529693 -
Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population
|
N/A | |
Recruiting |
NCT05415397 -
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
|
Phase 3 | |
Recruiting |
NCT05670301 -
Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases
|
N/A | |
Recruiting |
NCT04543877 -
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
|
Early Phase 1 | |
Recruiting |
NCT05775731 -
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
|
||
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03429920 -
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
|
N/A | |
Completed |
NCT06065241 -
Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.
|
N/A | |
Completed |
NCT05864352 -
The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
|
||
Completed |
NCT03318731 -
Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males
|
N/A | |
Not yet recruiting |
NCT06134076 -
Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota
|
N/A | |
Not yet recruiting |
NCT06159543 -
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
|
N/A |